Navigation Links
CorMatrix Cardiovascular to Present Data on Its Next Generation ECM Technology(TM) at Annual Transcatheter Cardiovascular Therapeutics (TCT) Conference in Washington, D.C.
Date:10/10/2008

WASHINGTON, Oct. 10 /PRNewswire/ -- CorMatrix Cardiovascular, Inc., an Atlanta-based company dedicated to developing and delivering unique extracellular matrix (ECM(TM)) biomaterial devices that harness the body's innate ability to repair damaged cardiovascular tissue, today announced that Robert G. Matheny, M.D., Chief Scientific Officer, will present data on the company's next generation ECM Technology(TM) at the annual Transcatheter Cardiovascular Therapeutics (TCT) 2008 conference in Washington, D.C. next week.

The presentation entitled "Cell Therapy Devices and Concepts: Acellular Matrix Emulsion Injections to Induce Myofibroblast Proliferation and Angiogenesis" will take place on Monday, October 13th at 1:35 p.m. EDT in room 145AB as part of the Innovative Devices and Futuristic Therapies Session.

"We are very proud to have Dr. Matheny included to present preclinical data from our next generation product within this prestigious panel," commented Beecher Lewis, President and Chief Operating Officer of CorMatrix Cardiovascular. "Our inclusion in this session reinforces the fact that our technology continues to gain interest and acceptance among the cardiovascular community."

About CorMatrix ECM Technology(TM)

CorMatrix Cardiovascular holds an exclusive license from Purdue University to research, develop, manufacture and market naturally occurring ECM products for cardiovascular applications. The company currently has U.S. clearance and European approval with a CE Mark to market its ECM Technology as an implant for pericardial closure, clearance in the U.S. for cardiac tissue repair, and is conducting preclinical studies on a number of cardiovascular applications including an emulsified, injectible form of its ECM Technology as a potential treatment for heart failure.

About CorMatrix Cardiovascular, Inc.

CorMatrix Cardiovascular, a privately held company based in Atlanta, Georgia, is dedicated to developing and del
'/>"/>

SOURCE CorMatrix Cardiovascular, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. CorMatrix(R) Announces FDA 510(k) for Novel Biomaterial Implant for Intracardiac Repair
2. Core Laboratories Joint Venture Agreement Between genae associates, VIBGYOR Scientific Research, Cardiovascular Center Aalst and J.B. Dahm
3. Physician to Implant the CATANIA(TM) Coronary Stent System With Polyzene(R)-F to Treat Chronic Total Occlusion During Live Case at the Paris Cardiovascular Interventions Course (Francophone) 2008
4. Nuvelo and ARCA biopharma Announce Merger Agreement Creating Late-Stage Cardiovascular Biotechnology Company
5. VIA Pharmaceuticals to Host Investor Science Briefing on the Role of Inflammation in Cardiovascular Disease on Tuesday, September 16
6. Terumo Cardiovascular Systems Files Patent Infringement Complaint Against Maquet Affiliates
7. Expert Consensus Panel Recommendation for Incorporating Lp-PLA2 Testing into Cardiovascular Disease Risk Assessment Guidelines
8. HemoCue Receives First FDA CLIA Waiver in Diagnostics Industry for Quantitative Point-of-Care Test for Microalbuminuria, a Kidney and Cardiovascular Disease Risk Marker
9. The Gladstone Institutes and iZumi Bio Announce Broad Partnership in Regenerative Medicine and Cardiovascular Disease
10. Stable Stroke Patients More Likely to Die From a Nonstroke Cardiovascular Event Than a Further Stroke
11. CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&D Partnership

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...O,Calif.,Nov.24/PRNewswire-FirstCall/--NeurogesX,I...dondevelopingandcommercializingnovelpainmanagement...ntandChiefExecutiveOfficer,isscheduledtopresentatt...eldDecember1-2,2009atTheNewYorkPalaceHotelinNewYor...efFinancialOfficer,willbeavailabletorespondtoquest...
(Date:11/24/2009)...URE:HTL , TORONTO,Nov.24/PRNewswire-FirstCall...italInc.,aleadingproviderofadvancedlasersystemsand...cmarkets,todayreportedoperationalandfinancialresul...009Highlights,-Revenuewas$1.46millioncomparedwith...entcomparedwith66.1percentinQ3,2008,-Netlossreduce...
(Date:11/24/2009)... Program Connects Customers with Partner...ed with DNA Genotek Products , ... Genotek , a leading provider of products for biol...ation, today announced its new global partner prog...or DNA Genotek,s partner community and is designed...
(Date:11/23/2009)...ting promises ultra-fast communication, computatio...rmation. But trying to use quantum states as carri...ss. Now two physicists have shown, mathematically,... communication, while keeping the information inta... Physical Review Letters and highlighted with a ...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...ech businesses will soon have a chance to network ...n. , ,The Japan External Trade Organization, or JE...leges and corporations to Japan this September 25 ...conferences, visit research centers and network wi...just this March led a trade mission to China, will...
...eceived a two-year Phase II Small Business Innova...tal 2004 SBIR funding to $3.29 million, the compan...rch Projects Administration gives SBIR funding to...elopment. Platypus, award is the typical maximum a...ill use the money to develop a prototype of a rapi...
...ource: Imago MADISON, Wis. Mass storage vendor ...adison-based Imago Scientific Instruments to mee...d hard drives. , ,Imago announced Tuesday that Sea...e analytical tool for the development of advanced ...o the company, The LEAP Microscope has proven succ...
Other Biology Technology:40 Midwest biotech organizations to explore Japanese partnerships 240 Midwest biotech organizations to explore Japanese partnerships 340 Midwest biotech organizations to explore Japanese partnerships 4Platypus keeps gathering federal funding with $750,000 for defense research 2
(Date:11/25/2009)...OVEMBER 25, 2009 Soil is the linchpin of the envi...ere meet. Despite that, many students see soil as ...ore. Soil science educators are challenged with th...e the critical importance of soil in the environme...nd earth science teachers at University of Nebrask...
(Date:11/24/2009)...of years it has been prescribed by traditional hea...eadaches and stomach pain to fever and flu. , Now...ersity have been able to scientifically prove the ...erwise known as Brazilian mint. , Testing this an... researcher Graciela Rocha was able to show that w...
(Date:11/24/2009)...ep weakened and flabby arteries from collapsing ha...ose stents are no longer needed -- once the arteri...iously, doctors had no choice but to leave them in...versity,s Department of Biomedical Engineering has...t carries drugs where they,re needed, then dissolv...
Breaking Biology News(10 mins):It's not just dirt! 2Got a pain? -- Have a cup of Brazilian mint 2A coating for life 2Too Much Computer Gaming Can Steal Your Sleep 48151 1Too Much Computer Gaming Can Steal Your Sleep 48151 2Too Much Computer Gaming Can Steal Your Sleep 48151 3D Pharm Receives FDA Clearance to Commence a Phase III Trial of DP b99 in Acute Stroke Patients 12510 1D Pharm Receives FDA Clearance to Commence a Phase III Trial of DP b99 in Acute Stroke Patients 12510 2D Pharm Receives FDA Clearance to Commence a Phase III Trial of DP b99 in Acute Stroke Patients 12510 3Two Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride 48149 1Two Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride 48149 2Two Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride 48149 3Two Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride 48149 4
...ass. -- A pioneering study of wild chimpanzees has...tinely experience menopause, rebutting previous st...that female chimpanzees reach reproductive senesce...ent data from wild gorillas and orangutans, the fi...t Biology -- suggests that human females are rare ...
...tral, the Open Access publisher for Physics, Mathe...rship agreements with the CERN and DESY high-energ...e organizations will centrally cover article-proce...investigators in the peer-reviewed open access jou... professor Ken Peach of University of Oxford and R...
....Y., December 13, 2007 Nutrition 21, Inc. (NASDAQ...ium-based and omega-3 fish oil-based nutritional s...cal study that showed daily supplementation with 1...d cognitive function in older adults experiencing ...d, double-blind, placebo-controlled study were pre...
Other Biology News:Wild chimpanzees appear not to regularly experience menopause 2Top physics laboratories sign up to open access with PhysMath Central 2New clinical data shows chromium picolinate improves cognitive function 2New clinical data shows chromium picolinate improves cognitive function 3
5X StabilCoat Immunoassay Stabilizer from SurModics, Inc.
Mouse Anti-Human PARK2 Monoclonal Antibody, Unconjugated, Clone 1H4 from Novus Biologicals
Pokeweed Mitogen Spleen Cell Conditioned Medium, 25 mL from StemCell Technologies, Inc.
Mouse Anti-Human FMN2 Monoclonal Antibody, Unconjugated, Clone 4B8 from Novus Biologicals
Biology Products: